From CLL to Multiple Myeloma ‐ Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|174|6|985-989

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.174, Iss.6, 2016-09, pp. : 985-989

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Multiple myeloma

By  

TRENDS IN UROLOGY AND MEN'S HEALTH, Vol. 6, Iss. 1, 2015-01 ,pp. : 31-34

John Wiley & Sons Inc

Access to resources Recommend Favorite

MULTIPLE MYELOMA

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 3, Iss. 9, 1955-09 ,pp. : 725-730

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry

By  

Acta Haematologica, Vol. 122, Iss. 4, 2009-10 ,pp. : 200-210

Karger

Access to resources Recommend Favorite

Multiple Myeloma in the Elderly

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 42, Iss. 6, 1994-06 ,pp. : 653-664

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiangiogenic Therapy in Multiple Myeloma

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 208-213

Karger

Access to resources Recommend Favorite